Hollywood Movies Rarely Reflect Climate Change Crisis. These Researchers Want to Change That

This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
TT

Hollywood Movies Rarely Reflect Climate Change Crisis. These Researchers Want to Change That

This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)
This image released by Netflix shows Leonardo DiCaprio as Dr. Randall Mindy and Jennifer Lawrence as Kate Dibiasky in a scene from "Don't Look Up." (Niko Tavernise/Netflix via AP)

Aquaman might not mind if the oceans rise, but moviegoers might.

That's one of the takeaways from a new study conducted by researchers who set out to determine if today's Hollywood blockbusters are reflective of the current climate crisis. The vast majority of movies failed the “climate reality check” proposed by the authors, who surveyed 250 movies from 2013 to 2022.

The test is simple — the authors looked to see if a movie presented a story in which climate change exists, and whether a character knows it does. One film that passed the test was the 2017 superhero movie Justice League, in which Jason Momoa's Aquaman character says, “Hey, I don't mind if the oceans rise” to Ben Affleck's Bruce Wayne, The AP reported.

But most movies fell short — fewer than 10% of the 250 films passed, and climate change was mentioned in two or more scenes of fewer than 4% of the films. That's out of touch with a moviegoing public that wants “to see their reality reflected on screen,” said Colby College English professor Matthew Schneider-Mayerson, lead researcher on the study.

“The top line is just that the vast majority of films, popular films produced over the last 10 years in the United States, are not portraying the world as it is,” Schneider-Mayerson said. “They are portraying a world that is now history or fantasy — a world in which climate change is not happening.”

Researchers at Maine's Colby College published the study in April along with Good Energy, a Los Angeles-based environmental consultancy. The results were peer reviewed, and the authors are seeking publication in scientific journals. The researchers view the test as a way for audience members, writers and filmmakers to evaluate the representation of climate change on screen.

Some results were surprising. Movies that at first glance appear to have little overlap with climate or the environment passed the test. Marriage Story, Noah Baumbach's emotive 2019 drama about the collapse of a relationship, passed the test in part because Adam Driver's character is described as “energy conscious,” Schneider-Mayerson said.

The 2022 whodunnit Glass Onion and the 2019 folk horror movie Midsommar were others to pass the test. Some that were more explicitly about climate change, such as the 2021 satire Don't Look Up, also passed. But San Andreas, a 2015 movie about a West Coast earthquake disaster, and The Meg, a 2018 action movie set in the ocean, did not.

The authors narrowed the selection of movies by excluding films not set on Earth or set before 2006 or after 2100. They found streaming services had a higher percentage of movies that included climate change than the major studios did.

The study is “valuable for marketing purposes, informational purposes, data accumulation,” said Harry Winer, director of sustainability at the Kanbar Institute of Film and Television at the New York University Tisch School of the Arts. Winer, who was not involved in the study, said it could also help serve as an incentive to connect audiences with climate stories.

“The audience will be more open to hearing a dialogue about what is right and what is wrong,” Winer said. “It's a conversation starter.”

The study authors said they see the climate reality check as a kind of Bechdel-Wallace test for climate change. Alison Bechdel, a cartoonist, is credited with popularizing that test in the 1980s by incorporating her friend Liz Wallace's test about gender representation in film into a comic strip. The test asks if a movie includes at least two female characters who have a conversation about something other than a man.

Bechdel herself spoke highly of the study's climate test, which she described as “long overdue” in a social media post during this year's Academy Awards season. Bechdel said in an e-mail to The AP that “for a movie set in the present to ignore this existential threat just doesn't make sense anymore" in the age of climate change.

“I do worry that screenwriters might do it in a kind of rote way, which could be counterproductive, just like rote ‘strong female characters’ are," Bechdel said. "But injecting an awareness of our communal plight into the stories we ingest seems like a no-brainer.”



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”